ZymoGenetics Punches Bristol-Myers With Suit
Drug developer ZymoGenetics Inc. has hit Bristol-Myers Squibb Co. with a lawsuit, accusing the pharmaceutical giant of infringing on its patented fusion protein technology....To view the full article, register now.
Already a subscriber? Click here to view full article